Insider Transactions in Q1 2022 at Edwards Lifesciences Corp (EW)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2022
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
12,500
+0.37%
|
-
|
|
Mar 22
2022
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
32,550
-7.59%
|
$3,613,050
$111.4 P/Share
|
|
Mar 22
2022
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
12,500
-10.9%
|
-
|
|
Mar 22
2022
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,050
+26.6%
|
$946,050
$21.76 P/Share
|
|
Mar 14
2022
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
20,000
-23.68%
|
$2,080,000
$104.59 P/Share
|
|
Mar 14
2022
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+29.67%
|
$420,000
$21.76 P/Share
|
|
Mar 11
2022
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Open market or private sale
|
Direct |
11,660
-3.62%
|
$1,235,960
$106.06 P/Share
|
|
Mar 11
2022
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
11,660
+6.65%
|
$244,860
$21.76 P/Share
|
|
Mar 11
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
11,050
-8.55%
|
$1,171,300
$106.02 P/Share
|
|
Mar 11
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
11,050
+14.08%
|
$232,050
$21.76 P/Share
|
|
Mar 08
2022
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,242
-1.19%
|
$767,652
$106.38 P/Share
|
|
Mar 08
2022
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,242
+3.42%
|
$260,712
$36.75 P/Share
|
|
Mar 08
2022
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
3,675
-3.61%
|
$393,225
$107.6 P/Share
|
|
Mar 08
2022
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
3,675
+3.49%
|
$128,625
$35.2 P/Share
|
|
Feb 21
2022
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
319
-0.86%
|
$33,495
$105.62 P/Share
|
|
Feb 18
2022
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
20,000
-23.44%
|
$2,120,000
$106.18 P/Share
|
|
Feb 18
2022
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+29.67%
|
$420,000
$21.76 P/Share
|
|
Feb 15
2022
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
12,500
+0.37%
|
-
|
|
Feb 15
2022
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
32,550
-14.99%
|
$3,580,500
$110.27 P/Share
|
|
Feb 15
2022
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
12,500
-10.64%
|
-
|
|
Feb 15
2022
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,050
+26.6%
|
$946,050
$21.76 P/Share
|
|
Feb 11
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
11,050
-8.24%
|
$1,226,550
$111.74 P/Share
|
|
Feb 11
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
11,050
+14.08%
|
$232,050
$21.76 P/Share
|
|
Feb 08
2022
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
6,350
-6.08%
|
$698,500
$110.2 P/Share
|
|
Feb 08
2022
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
6,350
+5.73%
|
$133,350
$21.76 P/Share
|
|
Feb 08
2022
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
4,386
-1.09%
|
$478,074
$109.9 P/Share
|
|
Feb 08
2022
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
4,386
+2.13%
|
$157,896
$36.75 P/Share
|
|
Feb 08
2022
|
Kieran Gallahue Director |
SELL
Open market or private sale
|
Direct |
32,256
-90.38%
|
$3,548,160
$110.79 P/Share
|
|
Feb 08
2022
|
Kieran Gallahue Director |
BUY
Exercise of conversion of derivative security
|
Direct |
32,256
+47.47%
|
$709,632
$22.29 P/Share
|
|
Jan 28
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
11,050
-3.43%
|
$1,105,000
$100.47 P/Share
|
|
Jan 28
2022
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
11,050
+13.9%
|
$232,050
$21.76 P/Share
|
|
Jan 14
2022
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
10,000
-13.73%
|
$1,190,000
$119.74 P/Share
|
|
Jan 14
2022
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+21.09%
|
$210,000
$21.76 P/Share
|
|
Jan 07
2022
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
6,350
-6.08%
|
$774,700
$122.16 P/Share
|
|
Jan 07
2022
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
6,350
+5.73%
|
$133,350
$21.76 P/Share
|
|
Jan 06
2022
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
12,500
+0.38%
|
-
|
|
Jan 06
2022
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
32,550
-5.1%
|
$4,036,200
$124.37 P/Share
|
|
Jan 06
2022
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
12,500
-5.37%
|
-
|
|
Jan 06
2022
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,050
+16.2%
|
$946,050
$21.76 P/Share
|